All posts by: Michael Zand

About Michael Zand

Stem cell gene therapy could be key to treating Duchenne muscular dystrophy – UC Los Angeles

Continue reading

2016-02-12

UC Los Angeles

Stem cell gene therapy could be key to treating Duchenne muscular dystrophy
UC Los Angeles
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and Center for Duchenne Muscular Dystrophy at UCLA have developed a new approach that could eventually be used to treat Duchenne muscular …
Researchers find marker identifying most basic form of blood stem cellMedical Xpress
FDA: Florida Stem Cell Clinic Violates LawWGCU News
BioInformant Releases “Stem Cell Research Products, Opportunities, Tools, & Technologies – Market Size, Segments PR Newswire (press release)
Benzinga –Medgadget.com (blog)
all 16 news articles »
Continue reading

2016-02-11

California to join with Israel on stemcell research
Jweekly.com
Israel’s Ministry of Science signed a collaborative agreement with California’s stemcell research agency on Feb. 8 at a ceremony at Cedars-Sinai Medical Center in Los Angeles, committing funds for collaborative research projects between universities

Continue reading

2016-02-11

WGCU News

FDA: Florida Stem Cell Clinic Violates Law
WGCU News
The U.S Food and Drug Administration’s letter was addressed to Dr. Thomas A. Gionis, owner and chief surgeon of the Miami Stem Cell Treatment Center located in Boca Raton. Gionis also owns a stem cell treatment center in Irvine, Calif. The letter shows …
Researchers find marker identifying most basic form of blood stem cellMedical Xpress
BioInformant Releases “Stem Cell Research Products, Opportunities, Tools, & Technologies – Market Size, Segments PR Newswire (press release)
Unapproved Stem Cell Therapies, a Public Health MenaceThe Observer Star
Benzinga –Medgadget.com (blog)
all 16 news articles »
Continue reading

2016-02-11

PR Newswire (press release)

BioInformant Releases “Stem Cell Research Products, Opportunities, Tools, & Technologies – Market Size, Segments
PR Newswire (press release)
WASHINGTON, Feb. 11, 2016 /PRNewswire/ — BioInformant announces the February 2016 release of its global strategic report, “Stem Cell Research Products, Opportunities, Tools, and Technologies – Market Size, Segments, Trends, and Projections to 2020.
About Global Stem Cell Group:Benzinga
Stem cell sector sees need for regulations to be simplified and approval process to be seamlesspharmabiz.com
Global Stem Cells Group Announces New Clinic Opening in Quito, EcuadorPR Web (press release)

all 5 news articles »